載入...
Methods for the Construction of Recombinant Oncolytic Myxoma Viruses
Myxoma virus (MYXV) has proven to be an effective candidate for oncolytic virotherapy in many preclinical cancer models. As a nonhuman pathogen, MYXV does not need to overcome any preexisting antiviral immunity, and its DNA cannot integrate into the host genome, making it an extremely safe vector. M...
Na minha lista:
| 發表在: | Methods Mol Biol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8082691/ https://ncbi.nlm.nih.gov/pubmed/33108657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-0716-1012-1_4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|